American Century Companies’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
ACM
KGAMU
6CM
AA
American Century Companies's CDLX Position: Q2 2021 in Review
American Century Companies sold out of Cardlytics (CDLX) in Q2 2021, closing a stake of 237 shares — an estimated $260K sold.
American Century Companies first reported a position in CDLX in Q4 2020 and held it in 2 quarters. The position peaked at $338K in Q4 2020. 189 funds tracked by Wall St. Rank hold CDLX as of Q2 2021.
- American Century Companies reported no remaining Cardlytics position as of Q2 2021 after selling out during the quarter.
- American Century Companies sold 237 Cardlytics shares in Q2 2021, an estimated $260K.
- American Century Companies first reported a position in Cardlytics in Q4 2020 and held it in 2 quarters.
- American Century Companies's Cardlytics position peaked at $338K in Q4 2020.
- 189 funds tracked by Wall St. Rank held Cardlytics as of Q2 2021.
Based on American Century Companies's 13F filing for Q2 2021, filed 5 Aug 2021.